- Home
- ECOR vs PRT Comparison
ECOR vs PRT Comparison
Compare ECOR & PRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ECOR | PRT |
|---|---|---|
| Founded | 2005 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.0M | 43.9M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | ECOR | PRT |
|---|---|---|
| Price | $6.49 | $3.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $22.00 | N/A |
| AVG Volume (30 Days) | ★ 49.2K | 42.8K |
| Earning Date | 04-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.29% |
| EPS Growth | ★ 53.51 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $25,182,000.00 | N/A |
| Revenue This Year | $28.92 | N/A |
| Revenue Next Year | $32.50 | N/A |
| P/E Ratio | ★ N/A | $7.78 |
| Revenue Growth | ★ 57.09 | N/A |
| 52 Week Low | $4.16 | $2.61 |
| 52 Week High | $13.81 | $4.42 |
Technical Indicators
Market Signals| Indicator | ECOR | PRT |
|---|---|---|
| Relative Strength Index (RSI) | 46.83 | 52.63 |
| Support Level | $4.64 | $3.28 |
| Resistance Level | $6.61 | $4.09 |
| Average True Range (ATR) | 0.70 | 0.11 |
| MACD | -0.06 | 0.00 |
| Stochastic Oscillator | 25.73 | 55.38 |
Price Performance
Historical ComparisonAbout ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About PRT PermRock Royalty Trust Trust Units
PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.